Article Details

Vigil Neuroscience to Present Key Considerations for Lead Indication ALSP at the 2022 ...

Retrieved on: 2022-03-03 21:33:42

Tags for this article:

Click the tags to see associated articles and topics

Vigil Neuroscience to Present Key Considerations for Lead Indication ALSP at the 2022 .... View article details on hiswai:

Excerpt

CAMBRIDGE, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up